Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria

This study is currently recruiting participants.
Information provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Hyperoxaluria
2		Additional conditions recognized in this trial
			Hyperoxaluria, Primary
3		More general conditions related to this trial
			Carbohydrate Metabolism, Inborn Errors
			Genetic Diseases, Inborn
			Kidney Diseases
			Metabolic Diseases
			Metabolism, Inborn Errors
			Urologic Diseases
4		Interventions listed in this trial
			ARB /Angiotensin Receptor Blocker
			Placebo
5		Additional drug interventions recognized in this trial
			Lisinopril
			Losartan
6		More general drug interventions related to this trial
			Angiotensin II Type 1 Receptor Blockers
			Angiotensin-Converting Enzyme Inhibitors
			Anti-Arrhythmia Agents
			Antihypertensive Agents
			Cardiotonic Agents
			Cardiovascular Agents
			Enzyme Inhibitors
			Molecular Mechanisms of Pharmacological Action
			Pharmacologic Actions
			Physiological Effects of Drugs
			Protease Inhibitors
			Protective Agents
			Therapeutic Uses
7		Sponsors listed in this trial
			National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)